OTCMKTS:BRTX BioRestorative Therapies (BRTX) Stock Price, News & Analysis $1.46 +0.01 (+0.69%) As of 10:15 AM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartHeadlinesInsider TradesSEC FilingsBuy This Stock About BioRestorative Therapies Stock (OTCMKTS:BRTX) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get BRTX alerts:Sign Up Key Stats Today's Range$1.46▼$1.4850-Day Range$1.41▼$1.8452-Week Range$1.21▼$2.55Volume3,146 shsAverage Volume195,591 shsMarket Capitalization$11.65 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview BioRestorative Therapies, Inc. (OTCMKTS:BRTX) is a clinical-stage biotechnology company dedicated to developing regenerative medicine therapies for urological, orthopedic and rehabilitative indications. The company’s research focuses on autologous and allogeneic cell therapy platforms designed to repair, regenerate and restore normal tissue function through targeted cell delivery and expansion technologies. Among its lead programs is BRTX-100, an investigational autologous muscle cell therapy aimed at treating stress urinary incontinence, which is advancing through late-stage clinical studies. The company is also developing BRTX-200, a muscle-derived cell therapy for male erectile dysfunction, along with early-stage programs targeting tendon and ligament injuries. These therapies employ minimally invasive cell harvesting and processing methods to reduce immune risk and enhance patient outcomes. Headquartered in Culver City, California, BioRestorative Therapies collaborates with clinical research centers and regulatory agencies across the United States to conduct its trials. Its scientific team brings together expertise in cell biology, tissue engineering and clinical development, guiding the translation of laboratory discoveries into potential commercial treatments. The company is committed to addressing unmet medical needs by harnessing the body’s own healing capabilities.AI Generated. May Contain Errors. Read More Receive BRTX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for BioRestorative Therapies and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. BRTX Stock News HeadlinesBioRestorative Therapies, Inc. (NASDAQ:BRTX) Q2 2025 Earnings Call TranscriptAugust 13, 2025 | insidermonkey.comBioRestorative Therapies CEO Lance Alstodt to Appear on Benzinga All-Access Show on June 18, 2025June 20, 2025 | nasdaq.comTrump’s Plan May Undo 1933’s Biggest Financial InjusticeTrump's Reset Can Give Birth To America's Greatest Era Yet A 90-Year cycle may end soon, creating real wealth for early adopters In 1933, Executive Order 6102 forced everyday Americans to hand over their gold at a fixed rate. Everyday citizens lost a sizable amount of their hard earned wealth at the stroke of FDR's pen.September 19 at 2:00 AM | American Hartford Gold (Ad)BIORESTORATIVE THERAPIES Earnings Results: $BRTX Reports Quarterly EarningsMay 16, 2025 | nasdaq.comLeveraging Stem Cells To Fight Chronic Lower Back Pain And Obesity With BioRestorative TherapiesMay 7, 2025 | msn.comBioRestorative Therapies Receives FDA Fast Track Approval For BRTX-100 To Treat Chronic Lumbar Disc DiseaseApril 18, 2025 | theglobeandmail.comBioRestorative to Provide a Positive FDA Update on Clinical PipelineFebruary 25, 2025 | finance.yahoo.comBioRestorative Therapies- BRTX-100 program receives FDA Fast Track designationFebruary 20, 2025 | markets.businessinsider.comSee More Headlines BRTX Stock Analysis - Frequently Asked Questions How have BRTX shares performed this year? BioRestorative Therapies' stock was trading at $1.43 on January 1st, 2025. Since then, BRTX shares have increased by 2.1% and is now trading at $1.46. When did BioRestorative Therapies' stock split? BioRestorative Therapies's stock reverse split before market open on Wednesday, October 27th 2021.The 1-4000 reverse split was announced on Wednesday, October 27th 2021. The number of shares owned by shareholders was adjusted after the market closes on Wednesday, October 27th 2021. An investor that had 100 shares of stock prior to the reverse split would have 0 shares after the split. How do I buy shares of BioRestorative Therapies? Shares of BRTX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of BioRestorative Therapies own? Based on aggregate information from My MarketBeat watchlists, some other companies that BioRestorative Therapies investors own include Tonix Pharmaceuticals (TNXP), Vaxart (VXRT), Inovio Pharmaceuticals (INO), Actinium Pharmaceuticals (ATNM), NVIDIA (NVDA), Onconova Therapeutics (ONTX) and American Graphite Technologies (AGIN). Company Calendar Today9/19/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Biotechnology Sub-IndustryHealthcare Current SymbolOTCMKTS:BRTX CIK1505497 Webwww.biorestorative.com Phone(631) 760-8100FaxN/AEmployees7Year Founded1997Profitability EPS (Trailing Twelve Months)($1.27) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$18.50 million Net Margins-13,728.83% Pretax Margin-13,728.83% Return on Equity-120.47% Return on Assets-114.48% Debt Debt-to-Equity RatioN/A Current Ratio14.81 Quick Ratio14.81 Sales & Book Value Annual Sales$605.20 thousand Price / Sales19.11 Cash FlowN/A Price / Cash FlowN/A Book Value$2.65 per share Price / Book0.55Miscellaneous Outstanding Shares7,978,000Free Float3,660,000Market Cap$11.57 million OptionableNot Optionable Beta-0.43 Social Links The Best High-Yield Dividend Stocks for 2025Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.Get This Free Report This page (OTCMKTS:BRTX) was last updated on 9/19/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredTrump’s Plan May Undo 1933’s Biggest Financial InjusticeTrump's Reset Can Give Birth To America's Greatest Era Yet A 90-Year cycle may end soon, creating real weal...American Hartford Gold | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredA New Way to Double Your Retirement Income?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...Investors Alley | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredStrange crypto pattern discovered by 40-person research teamSomething unusual is happening inside a 40-person crypto research firm. They're helping 8,000+ ordinary peo...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioRestorative Therapies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BioRestorative Therapies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
